Combining Pristiq and Prozac for Skin Picking: Not Recommended
This combination should be avoided due to significant risk of serotonin syndrome when combining an SNRI (desvenlafaxine/Pristiq) with an SSRI (fluoxetine/Prozac), and neither medication is established as effective for excoriation disorder. 1, 2
Primary Safety Concern: Serotonin Syndrome Risk
The most critical issue with combining Pristiq 50mg and Prozac 10mg is the elevated risk of serotonin syndrome. Guidelines explicitly warn that caution must be exercised when combining two or more non-MAOI serotonergic drugs, including SNRIs and SSRIs 1.
Serotonin Syndrome Presentation:
- Mental status changes: confusion, agitation, anxiety
- Neuromuscular hyperactivity: tremors, clonus, hyperreflexia, muscle rigidity
- Autonomic hyperactivity: hypertension, tachycardia, arrhythmias, diaphoresis, vomiting, diarrhea
- Advanced symptoms: fever, seizures, arrhythmias, unconsciousness leading to fatalities 1
The FDA label for Pristiq specifically cautions about serotonin syndrome risk with concomitant use of other serotonergic agents, including SSRIs 2. While the guideline notes that combining two serotonergic drugs can be done with extreme caution (starting low, titrating slowly, monitoring closely in first 24-48 hours after dose changes) 1, this approach is not justified for skin picking given the lack of evidence for efficacy.
Lack of Evidence for Skin Picking Treatment
For Desvenlafaxine (Pristiq):
- No evidence supports desvenlafaxine for excoriation/skin-picking disorder
- Desvenlafaxine is FDA-approved only for major depressive disorder 2
- A pediatric trial of desvenlafaxine for depression actually failed to show efficacy 3
For Fluoxetine (Prozac):
- Limited evidence exists: One small double-blind trial (n=21, only 17 completers) showed fluoxetine was superior to placebo on 2 of 3 measures for skin picking 4
- A 2016 meta-analysis found SSRIs had a large effect size (g=1.09) for excoriation disorder, but this was based on very limited data 5
- A 2025 review suggests SSRIs show "the most promising results" for skin picking, but acknowledges the evidence base remains thin 6
Clinical Guideline Perspective on Combination Antidepressants
The 2009 AACAP practice parameter explicitly states: "There is limited evidence in children and adolescents for the use of two antidepressants...as an initial treatment approach or as a specific endpoint for treatment" 7. While this guideline addresses pediatric populations, the principle applies: combining two serotonergic antidepressants requires strong justification and is typically reserved for treatment-resistant cases, not as initial therapy.
Recommended Approach for Skin Picking
First-line treatment for excoriation disorder should be:
Habit-reversal therapy/CBT as primary intervention 6
If pharmacotherapy is needed, consider:
If SSRI monotherapy fails, consider:
Critical Pitfalls to Avoid
- Do not combine two serotonergic antidepressants without compelling evidence of treatment resistance and clear documentation of risk-benefit discussion
- Do not use desvenlafaxine for skin picking—it has no evidence base for this indication
- Monitor closely if any serotonergic combination is unavoidable: check for tremor, agitation, diaphoresis, GI symptoms, vital sign changes within 24-48 hours of initiation 1
- The Pristiq label explicitly warns patients not to take it with other products containing desvenlafaxine or venlafaxine, and to report symptoms when combining with other serotonergic agents 2
In summary: Choose either Prozac alone (10-20mg, can titrate up) OR consider N-acetylcysteine, but do not combine Pristiq and Prozac for skin picking.